Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 70Squamous Cell Carcinoma of Head and Neck 32Parkinson Disease 4, Autosomal Dominant Lewy Body 30Lung Neoplasms 28Melanoma 24Triple Negative Breast Neoplasms 23Neoplasms 20Neoplasm Metastasis 20Breast Neoplasms 19Colorectal Neoplasms 18Head and Neck Neoplasms 15Endometrial Neoplasms 15Ovarian Neoplasms 14Carcinoma, Renal Cell 13Urinary Bladder Neoplasms 11Carcinoma, Transitional Cell 10Pancreatic Neoplasms 7Hodgkin Disease 7Esophageal Neoplasms 7Uterine Cervical Neoplasms 6Sarcoma 6Recurrence 6Lymphoma 6Carcinoma 6Stomach Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Multiple Myeloma 4Mouth Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4

Interventions

Nivolumab 2sacituzumab govitecan 1relatlimab 1pembrolizumab 1erdafitinib 1enfortumab vedotin 1avelumab 1Vinblastine 1Specimen Handling 1Paclitaxel 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Gemcitabine 1Disulfides 1Cystoscopy 1Cisplatin 1Circulating Tumor DNA 1Cell-Free Nucleic Acids 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Muscle Invasive Bladder Urothelial Carcinoma × pembrolizumab × 30 days × Clear all
NCT06204614 2026-05-18

Drug Screening Using IMD in Bladder Cancer

Brigham and Women's Hospital

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Muscle Invasive Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡